Menu

5 min read

Gnosis By Lesaffre Joins ILSI Europe’s New Vitamin K2 Task Force

Published on
March 14, 2024
Gnosis by Lesaffre Joins ILSI Europe’s New Vitamin K2 Task Force

    Achieving Stronger Bone & Heart Health

     

    With ever-growing evidence of the importance of Vitamin K2, not only for stronger bone and heart health but also for other critical functions in the body, raising public awareness is crucial. As Gnosis by Lesaffre joins ILSI’s newly established Task Force on Vitamin K2, we are taking a joint step further.

     

    ILSI Europe (International Life Sciences Institute) fosters collaboration among leading scientists to provide evidence-based scientific consensus on nutrition, food safety, toxicology, risk assessment, and the environment. In February 2024, it launched a new task force on Vitamin K2 to advance health understanding and economic insights.

     

    Building on A Foundation of Clinical Research

     

    ILSI’s newly formed task force signifies the solid scientific foundation of Vitamin K2 as MK-7. MenaQ7®, known as the most clinically proven vitamin K2 as MK-7 in the market, has demonstrated support for strong bone health in both children and adult populations, as well as supporting robust cardiovascular health.

     

    Despite the significance of K2, awareness and understanding among the public remain relatively low. The ILSI Task Force represents a crucial step in bridging the gap between scientific awareness and public understanding.

     

    Increasing K2 Awareness – A Potential for Health Cost Savings

     

    The Task Force’s main objective is to assess the scientific evidence that supports various health benefits linked to Vitamin K2. It aims to identify and evaluate potential biomarkers for monitoring Vitamin K2 status. Further, it will conduct a comprehensive nutrition economic study to determine the potential healthcare cost savings for Europe associated with Vitamin K2 supplementation.

     

    A Panel of Vitamin K2 Experts

     

    Gnosis by Lesaffre has been a pioneering force in shaping the Vitamin K2 industry, and brings MenaQ7®, the most clinically proven K2 as MK-7 for bone and heart health to the market. Our commitment to clinical validation, rigorous scientific standards, and the development of innovative, efficacious products aligns seamlessly with the values of ILSI Europe, making us a natural and integral member of this new Task Force on Vitamin K2.

     

    We are excited to expand our dedication to educating and raising awareness about the health benefits of vitamin K2, now through our involvement in the ILSI Task Force on K2.

    Deep Dive Into K2

    Significant research shows vitamin K2 from natural fermentation – especially its key long chain isomers MK-7 – to be essential for bone and cardiovascular-health support.